Paranoia is not just a symptom of “feeling uneasy” it shows up in psychotic disorders at rates most people never see until they are looking closely. Roughly 0.9% of U.S. adults reported psychotic symptoms in the past year while global estimates put paranoia related experiences in the same orbit as schizophrenia, which accounts for about 0.7% lifetime prevalence worldwide. At the same time, the mental health support gap is wide with 31.1% of adults with serious mental illness reporting unmet need for care, making the statistics feel personal rather than abstract.
Key Takeaways
- 5.1% of U.S. adults (12.8 million) had substance use disorder in 2022 (National Survey on Drug Use and Health).
- 3.6% of U.S. adults reported experiencing any mental illness in 2019 (National Alliance on Mental Illness citing NIMH/NSDUH estimates).
- 31.1% of adults with serious mental illness reported unmet need for mental health services (2019 National Survey of Substance Abuse).
- $326 billion: estimated U.S. spending on mental health services in 2022 (data summarized by NAMI using CMS/NHSS series).
- $200 billion: estimated global market size for mental health apps in 2023 (vendor market-sizing statement).
- $1.6 billion global market size for digital therapeutics for mental health in 2022 (IMF/consulting market sizing summarized by vendor research).
- 67% of U.S. healthcare organizations reported using some form of telehealth by 2021 (HIMSS survey).
- In 2023, 91% of health systems said cybersecurity is a top concern (2023 HIMSS survey).
- 2023: The global mental health software market grew at a CAGR of 11.2% from 2018–2023 (vendor market report).
- 33% of healthcare organizations have implemented MFA for at least some users (Verizon DBIR 2023/industry security survey).
- 48% of healthcare executives reported using patient-facing portals (2022 HIMSS Analytics).
- 12.0% of U.S. adults reported using mobile health apps for health in 2022 (Pew Research Center survey).
- In 2023, 71% of U.S. hospitals had implemented sepsis screening (CMS quality measure).
- Improvement: cognitive behavioral therapy (CBT) for psychosis shows moderate effect sizes (Hedges g ~0.5) in meta-analyses (2014–2020 literature).
- Family interventions for schizophrenia reduce relapse by about 20% (relative reduction ~20%; Cochrane review).
Paranoia symptoms are common in psychotic disorders, yet mental health care needs and privacy gaps persist widely.
Related reading
01 · Category
Health Statistics9 stats
01
5.1% of U.S. adults (12.8 million) had substance use disorder in 2022 (National Survey on Drug Use and Health).
02
3.6% of U.S. adults reported experiencing any mental illness in 2019 (National Alliance on Mental Illness citing NIMH/NSDUH estimates).
03
31.1% of adults with serious mental illness reported unmet need for mental health services (2019 National Survey of Substance Abuse).
04
1 in 5 U.S. adults experience mental illness each year (2005–2010 pooled estimate referenced by NIMH; commonly used baseline).
05
Schizophrenia accounted for 0.5% of global disability-adjusted life years (2019 Global Burden of Disease).
06
Delusional disorder is estimated to affect ~0.2% of the population (meta-analytic estimate; cited in DSM-5-related epidemiology summaries).
07
Overall prevalence of psychotic disorders is estimated at ~0.3% globally (peer-reviewed systematic review estimate).
08
Paranoia-related symptoms are among the most common symptoms in psychotic disorders; schizophrenia lifetime prevalence is ~0.7% (worldwide meta-analysis estimate).
09
0.9% of U.S. adults reported psychotic symptoms in the past year (National Comorbidity Survey replication estimate).
Interpretation
Health Statistics Interpretation
From a Health Statistics perspective, the data show that while only about 0.9% of U.S. adults report psychotic symptoms in the past year, mental health needs remain large with 3.6% reporting any mental illness and 31.1% of adults with serious mental illness lacking needed services.
02 · Category
Market Size10 stats
01
$326 billion: estimated U.S. spending on mental health services in 2022 (data summarized by NAMI using CMS/NHSS series).
02
$200 billion: estimated global market size for mental health apps in 2023 (vendor market-sizing statement).
03
$1.6 billion global market size for digital therapeutics for mental health in 2022 (IMF/consulting market sizing summarized by vendor research).
04
$2.9 billion global market size for mental health services software in 2023 (market research estimate).
05
$14.9 billion: global telehealth market size in 2023 (Telehealth market sizing by Allied Market Research).
06
$9.2 billion: U.S. behavioral health outpatient services revenue in 2022 (CMS claims-based spending summary).
07
$7.8 billion: U.S. EHR market value in 2023 (vendor/industry estimate).
08
$40.3 billion: U.S. cloud services market size in 2023 (to contextualize privacy/security spend for health).
09
$2.1 billion: global spend on mental health and addiction analytics/insights tools in 2023 (market sizing by vendor research).
10
$3.3 billion: global market size for psychiatric digital platforms in 2023 (vendor market report).
Interpretation
Market Size Interpretation
The market size picture for Paranoia is clearly large and fast-moving, with spending and related software and services reaching $326 billion in U.S. mental health services in 2022 and expanding globally into multiple adjacent categories such as $14.9 billion in telehealth in 2023 and $2.9 billion for mental health services software in 2023.
03 · Category
Industry Trends3 stats
01
67% of U.S. healthcare organizations reported using some form of telehealth by 2021 (HIMSS survey).
02
In 2023, 91% of health systems said cybersecurity is a top concern (2023 HIMSS survey).
03
2023: The global mental health software market grew at a CAGR of 11.2% from 2018–2023 (vendor market report).
Interpretation
Industry Trends Interpretation
The industry trends point to a clear shift in healthcare toward digital services and protection priorities, with 67% of U.S. organizations using telehealth by 2021 and 91% of health systems naming cybersecurity a top concern in 2023 while the mental health software market keeps expanding at an 11.2% CAGR from 2018 to 2023.
More related reading
04 · Category
User Adoption10 stats
01
33% of healthcare organizations have implemented MFA for at least some users (Verizon DBIR 2023/industry security survey).
02
48% of healthcare executives reported using patient-facing portals (2022 HIMSS Analytics).
03
12.0% of U.S. adults reported using mobile health apps for health in 2022 (Pew Research Center survey).
04
10% of adults used an online mental health service in the past year (Pew Research Center; 2023).
05
9% of U.S. adults reported using a chatbot for health information (Pew Research Center; 2022).
06
26% of U.S. adults have used a wearable device to track health (Pew Research Center; 2022).
07
86% of nursing homes used electronic health records (CMS Nursing Home data; 2022).
08
77% of hospitals reported implementing electronic prescribing (ONC HIE/ONC hospital adoption summary).
09
29% of healthcare organizations had a formal AI governance program in 2023 (Gartner/IDC cited by industry press; governance adoption).
10
34% of consumers were willing to share health data with companies for personalized care in 2022 (Pew Research Center; privacy).
Interpretation
User Adoption Interpretation
User adoption is gradually building across healthcare channels, with 77% of hospitals using electronic prescribing and 86% of nursing homes using electronic health records, while digital engagement is also rising as 12% of U.S. adults use mobile health apps, 10% use online mental health services, and 9% use health chatbots.
05 · Category
Performance Metrics13 stats
01
In 2023, 71% of U.S. hospitals had implemented sepsis screening (CMS quality measure).
02
Improvement: cognitive behavioral therapy (CBT) for psychosis shows moderate effect sizes (Hedges g ~0.5) in meta-analyses (2014–2020 literature).
03
Family interventions for schizophrenia reduce relapse by about 20% (relative reduction ~20%; Cochrane review).
04
Assertive community treatment (ACT) reduces hospitalization by ~20% (meta-analysis).
05
Collaborative care for depression reduces depressive symptoms by ~0.3 standard deviations (meta-analysis).
06
Integrated care models for mental health and substance use increase treatment engagement by ~15% (systematic review).
07
Use of electronic patient reminders increases appointment adherence by ~14% (meta-analysis).
08
Digital interventions for anxiety disorders show small-to-moderate effect sizes (standardized mean difference ~0.5) in meta-analyses (2016–2019).
09
Mindfulness-based cognitive therapy reduces relapse risk by ~30% compared with controls (meta-analysis).
10
Long-acting injectable antipsychotics reduce relapse risk by ~30% vs oral for some populations (network meta-analysis).
11
Medication adherence interventions improve adherence by ~10–20% (Cochrane review range).
12
Exposure-based CBT for anxiety improves symptoms with effect size g ~0.8 (meta-analysis).
13
Cognitive therapy reduces psychotic symptoms by ~0.3 standard deviations (meta-analysis).
Interpretation
Performance Metrics Interpretation
Across these performance metrics, the clearest trend is that structured, evidence based care can produce clinically meaningful gains, with improvements clustering around roughly 15 to 30% better outcomes such as 71% sepsis screening adoption in 2023 and about 20% relapse and hospitalization reductions from family interventions and assertive community treatment.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Ryan Townsend. (2026, February 13). Paranoia Statistics. Gitnux. https://gitnux.org/paranoia-statistics
MLA
Ryan Townsend. "Paranoia Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/paranoia-statistics.
Chicago
Ryan Townsend. 2026. "Paranoia Statistics." Gitnux. https://gitnux.org/paranoia-statistics.
Sources & references
45 datasets cited across this report · attribution is report-level
+25 additional datasets cited (not shown individually)